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Abstract
Background: Hemophagocytic lymphohistiocytosis is a frequently fatal and likely underdiagnosed disease. It is a
rare occurrence in adults and usually secondary to an insult such as viral infections, bacterial infections, autoimmune
connective tissue disorders, malignancies and immunocompromised states, in contrast to its childhood counterpart,
which is due to a genetic defect but may share some of same genetic etiologies. It is characterized by multisystem
inflammation due to unregulated proliferation and infiltration of macrophages and CD8 T cells in the bone marrow,
which leads to phagocytosis of red blood cells, platelets, lymphocytes and their precursors.
Case presentation: A 40-year-old Sri Lankan woman presented with a high-grade fever of 2 weeks’ duration and the
initial workup, including a thorough clinical examination, and all the investigations, including a septic screen, were
normal. On the 18th day of hospital admission, she was found to have yellowish retinal lesions, which were confirmed
as choroid tubercles by the consultant eye surgeon. Two days later she became pancytopenic and a bone marrow
biopsy confirmed the diagnosis of hemophagocytic lymphohistiocytosis. She was treated with conventional category-1
antituberculous drugs and an initial 2 weeks with high-dose oral dexamethasone. All the choroid tubercles gradually
disappeared and she recovered completely without any complications.
Conclusions: In an adult patient with hemophagocytic lymphohistiocytosis, it is pivotal to understand the underlying
etiology, as it needs extensive immunosuppression. If this patient had been treated with immunosuppressants without
antituberculous medications, it would have been lethal with disseminated or central nervous system tuberculosis. So, in
areas where tuberculosis is endemic, if no underlying cause is found, it may be worth considering antituberculous
treatment for these patients. Re-evaluation with thorough clinical examination is of utmost importance in any patient
with pyrexia of unknown origin as well as in any disease with unusual manifestations.
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Background
Hemophagocytic lymphohistiocytosis (HLH) is a fre-
quently fatal rare disease entity which is due to aggressive
proliferation of histiocytes and T lymphocytes in various
tissues [1–4]. It leads to phagocytosis of red blood cells,
other white blood cells and platelets within bone marrow,
spleen and lymph nodes. The pathophysiology of HLH is
complex and thought to be due to the lack of perforin-
dependant cytotoxicity in natural killer and cytotoxic T
lymphocytes. It has a very aggressive course, which is po-
tentially life-threatening and usually affects genetically
susceptible children from birth to 18 months [3, 4]. Adult
disease is even more rare and considered “secondary
HLH” because it is triggered by a secondary insult such as
infections, autoimmune connective tissue disorders, im-
munodeficient states and malignancies, but there may be
some genetic predisposition as well [3]. Out of infections,
it commonly occurs secondary to viral infections such as
Epstein-Barr virus, cytomegalovirus, parvovirus, herpes
simplex, varicella-zoster, measles, human herpesvirus 8
and human immunodeficiency virus (HIV) alone or in
combination. Also, it can occur with various bacterial in-
fections (Brucella, Gram-negative bacteria, tuberculosis
(TB)), parasites (leishmaniasis) and fungal infections.
Autoimmune conditions that can act as triggers are sys-
temic lupus erythematosus (SLE), rheumatoid arthritis,
Still’s disease, polyarteritis nodosa (PAN), mixed connect-
ive tissue disease (MCTD), pulmonary sarcoidosis, sys-
temic sclerosis, Sjogren’s syndrome and drug reaction
with eosinophilia and systemic symptoms (DRESS). Other
rare associations are immunosuppressed conditions such
as in patients with immune deficiencies including X-
linked lymphoproliferative disease, common variable im-
munodeficiency and in renal or liver transplant recipients
[5–7].
At the initial stages these patients may mimic common
infective illnesses, pyrexia of unknown origin or hepa-
titis, with clinical findings such as lymphadenopathy and
hepatosplenomegaly, but in the latter stages they go into
cytopenias, which are potentially life-threatening if not
detected in time and treated with aggressive immuno-
suppressants [6, 8].
There are very few case reports in the world literature
regarding TB leading to HLH in immunocompetent pa-
tients and this is the first reported case in Sri Lanka,
which has high prevalence of TB.
Case presentation
A 40-year-old Sri Lankan woman from a small village close
to Kandy presented with on-and-off high-grade swinging
fever that she had had for 2 weeks. It was associated with
arthralgia and myalgia but she was otherwise well. There
was no long-standing cough, hemoptysis, alteration of
bowel habits, loss of weight or urinary symptoms. She was
clinically euthyroid and there was no history to suggest
connective tissue disorder. Her past medical history was
uneventful apart from childhood rheumatic fever, which
was treated with oral penicillin until the age of 21 years.
An initial clinical evaluation including a fundal examin-
ation was normal apart from mild pallor.
Initial investigations revealed a hemoglobin (Hb) level of
10.9 g/dL (mean corpuscular volume (MCV) 84 fL), white
blood cell count (WBC) of 13.7 × 103/μL (granulocytes
85.1 %, lymphocytes 8.1, minimum inhibitory dilution
6.8 %), platelets 383 × 103/μL, erythrocyte sedimentation
rate (ESR) of 121 mm, C-reactive protein (CRP) of
84.5 mg/dL, aspartate transaminase (AST) of 61.1 U/L,
alanine transaminase (ALT) of 63.7 U/L, serum protein of
7.84 g/dL, serum albumin of 4.02 g/dL, serum bilirubin
(total) of 5.7 μmol/L, alkaline phosphatase of 210 U/L,
gamma-glutamyl transferase of 23 U/L, international nor-
malized ratio (INR) of 1.01, red blood cell count (RBS) of
4.5 mol/L, serum creatinine of 0.8 mg %, serum sodium of
139 mmol/L, and serum potassium of 4.3 mmol/L. Also, a
septic screen including three blood cultures and a urine
culture, a chest X-ray and electrocardiogram (ECG) were
normal. The blood picture revealed moderate rouleaux
formation and polymorphonuclear leukocytosis with cyto-
plasmic vacuolations suggestive of bacterial infection or
inflammation with anemia of chronic disease.
She was treated with broad-spectrum antibiotics
(ceftriaxone 1 g 12 hourly) and doxycycline for possible
rickettsial infection but our patient still continued to have
high-grade fever spikes. Hence she underwent second-line
investigations including an abdominal ultrasound scan,
thick and thin films for malaria, a rheumatoid factor,
antinuclear antibody (ANA), and Mantoux test, induced
sputum test for acid-fast bacilli, HIV serological test and
venereal disease research laboratory (VDRL) test but all
results were negative. She was regularly reassessed and on
the 18th day of hospital admission found to have yellowish
fleshy lesions in her left fundus. They gradually increased
in number and extended to the other eye as well. In
addition, she was found to have hepatosplenomegaly.
Her clinical condition rapidly deteriorated with very
high fever spikes (Fig. 1).
Repeat investigations revealed a Hb level of 7.7 g/dL
(MCV of 84 fL), WBC of 1.7 × 103/ μL (granulocytes
39 %, lymphocytes 31 %, minimum inhibitory dilution
30 %), platelets 49 × 103/μL, ESR of 10 mm, CRP of
93.7 mg/dL, AST of 1705 U/L, ALT of 286 U/L, serum
protein of 5.7 g/dL, serum albumin of 3.2 g/dL, serum
bilirubin (total) of 25.42 μmol/L, direct bilirubin of
10.1 μmol/L alkaline phosphatase of 724 U/L, gamma-
glutamyl transferase of 344.9 U/L, INR of 1.68, and
lactate dehydrogenase (LDH) of 1580 U/L. Results of a
repeat septic screen were again negative and a chest X-
ray did not reveal any significant pathology including
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miliary mottling. As she was pancytopenic we went
ahead with a bone marrow biopsy. It showed increased
macrophage activity with engulfed red blood cells,
neutrophils and platelets suggestive of hemophagocytic
lymphohisteocytosis. There were no visible granulomas.
Her serum ferritin value was very high (60,587 ng/mL)
with elevated triglycerides (396.3 mg/dL) and her serum
fibrinogen level was low (100 mg/dL). A bone marrow
culture did not grow acid-fast bacilli (Fig. 2).
She fulfilled criteria for HLH, and because of multiple
choroid tubercles in both fundi, TB infection was
considered as the trigger [6, 8].
Discussion
She was treated with high doses of immunosuppressant
intravenous methylprednisolone 1 g daily for 3 days
followed by a short course of oral dexamethasone for
2 weeks and conventional category 1 anti-TB drugs for
9 months under the supervision of a consultant chest
physician. Her deranged liver function test results were
attributed to both TB as well as HLH and monitored
closely. A liver biopsy was not performed because of her
deranged clotting profile. She responded dramatically
and her fever settled in crisis with the first dose of intra-
venous methylprednisolone. The choroid tubercles grad-
ually disappeared after 10 days of anti-TB treatment and
her liver function gradually improved without any com-
plications from the anti-TB drugs. She totally recovered
from her illness and there has been no relapse up to
now, 18 months after her original illness.
Conclusions
HLH is an uncommon clinical manifestation and, if not
suspected early, it can be fatal. In an adult patient
especially, it is very important to look for the underlying
trigger such as bacterial infections, connective tissue
disorders or malignancies because it needs definitive man-
agement. As the patient needs high-grade immunosup-
pression as the treatment for HLH, underlying bacterial
infections should be treated promptly [6, 8]. In this case, if
she had been treated with immunosuppressants without
antituberculous medications, the end result would have
been lethal. She was a healthy adult without any under-
lying immunosuppressive condition, but thorough and
repeated clinical examinations clinched the diagnosis of
extrapulmonary TB.
Therefore, although we have very sophisticated labora-
tory investigations, regular reassessments as well as
prompt clinical examination are still very important. Also,
in areas with high prevalence of TB, it is worth treating
HLH patients with anti-TB drugs if there is no secondary
cause found because it could be lifesaving.
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Fig. 1 Fluorescein-stained fundal photograph showing a
choroid tubercle
Fig. 2 Bone marrow biopsy showing red blood cells engulfed by
macrophages (pink arrow)
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